Mark J. Casey
General Counsel, Hologic.
Companies
- NovavaxGeneral counsel Dec 13, 2023 to now1
- Keenova Therapeutics plcGeneral counsel Feb 5, 2018 to Jun 21, 20222
- Idera SoftwareGeneral counsel Jul 1, 2015 to Jan 5, 20183
- HologicSVP, CAO, GC & Secretary Mar 10, 2014 to Nov 19, 20144
- HologicGeneral counsel Jan 17, 2008 to Nov 20, 20135
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Novavax NVAX90,067 shares6$1.2M at $12.82Mar 3, 2026- Keenova Therapeutics plc0 shares7Jun 16, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 3, 2026Shares withheld for tax 11,378 shares at $9.49 of Novavax6
- Mar 3, 2026Exercised options 37,500 shares of Novavax6
- Mar 1, 2026Shares withheld for tax 1,214 shares at $10.14 of Novavax8
- Mar 1, 2026Exercised options 4,000 shares of Novavax8
- Dec 11, 2025Shares withheld for tax 12,713 shares at $6.69 of Novavax9
- Dec 11, 2025Exercised options 41,899 shares of Novavax9
- Mar 1, 2025Shares withheld for tax 1,214 shares at $8.33 of Novavax10
- Mar 1, 2025Exercised options 4,000 shares of Novavax10
- Dec 11, 2024Shares withheld for tax 12,713 shares at $8.82 of Novavax11
- Dec 11, 2024Exercised options 41,900 shares of Novavax11
- Jun 16, 2022Returned to company 32,011 shares of Keenova Therapeutics plc7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARNovavax, General counsel
- 2
- 3SEC EDGARIdera Software, General counsel
- 4SEC EDGARHologic, SVP, CAO, GC & Secretary
- 5SEC EDGARHologic, General counsel
- 6
- 7
- 8SEC EDGARForm 4 filed Mar 3, 2026
- 9SEC EDGARForm 4 filed Dec 15, 2025
- 10SEC EDGARForm 4 filed Mar 4, 2025
- 11SEC EDGARForm 4 filed Dec 13, 2024